Mario Presti

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Immune Response

Mesenchymal Stem Cells

Tyrosine Kinase

Top Venues

Cancer immunology, immunotherapy : CII

Clinical cancer research : an official journal of the American Association for Cancer Research

International journal of molecular sciences

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Arianna Draghi, Mario Presti, Agnete Witness Præst Jensen, Christopher Aled Chamberlain, Benedetta Albieri, Anne-Christine K Rasmussen, Mads Hald Andersen, Michael Douglas Crowther, Inge Marie Svane, Marco Donia
Uncoupling CD4+ TIL-mediated tumor killing from JAK-signaling in melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Morten Nielsen, Mario Presti, Zsófia M Sztupinszki, Agnete Witness Præst Jensen, Arianna Draghi, Christopher Aled Chamberlain, Aimilia Schina, Christina Westmose Yde, John B Wojcik, Zoltan Szallasi, Michael Douglas Crowther, Inge Marie Svane, Marco Donia
Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post-PD-1 Immunotherapy. Cancer immunology research 10 (10) (2022)
Joachim Stoltenborg Granhøj, Agnete Witness Præst Jensen, Mario Presti, Özcan Met, Inge Marie Svane, Marco Donia
Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions. Expert opinion on biological therapy 22 (5) (2022)
Mario Presti, Marie Christine Wulff Westergaard, Arianna Draghi, Christopher Aled Chamberlain, Aishwarya Gokuldass, Inge Marie Svane, Marco Donia
The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro. Cancer immunology, immunotherapy : CII 70 (6) (2020)
Salvo Danilo Lombardo, Emanuela Mazzon, Maria Sofia Basile, Giorgia Campo, Federica Corsico, Mario Presti, Placido Bramanti, Katia Mangano, Maria Cristina Petralia, Ferdinando Nicoletti, Paolo Fagone
Modulation of Tetraspanin 32 (TSPAN32) Expression in T Cell-Mediated Immune Responses and in Multiple Sclerosis. International journal of molecular sciences 20 (18) (2019)